Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +3.15% slid 3.34% to $118.07 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.51% falling 2.84% to 10,737.51 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.0047% falling 1.54% to 29,225.61. This was the stock's second consecutive day of losses. Moderna Inc. closed $272.53 below its 52-week high ($390.60), which the company achieved on September 30th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +1.03% fell 1.30% to $142.72, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.87% fell 1.11% to $228.41, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.42% rose 0.40% to $54.91. Trading volume (4.7 M) remained 32,345 below its 50-day average volume of 4.7 M.